Marshall Wace
STIM icon

Marshall Wace’s Neuronetics STIM Stock Holding History

Marshall Wace’s Portfolio STIM Stock Details STIM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$631K Buy
+485,692
New +$707K ﹤0.01% 2412
2026
Q1 		– Sell
-286,045
Closed -$395K – 3656
2025
Q4 		$395K Sell
286,045
-639,065
-69% -$1.34M ﹤0.01% 2343
2025
Q3 		$2.53M Buy
925,110
+881,867
+2,039% +$3.13M ﹤0.01% 1495
2025
Q2 		$151K Sell
43,243
-11,275
-21% -$44.5K ﹤0.01% 2498
2025
Q1 		$201K Buy
+54,518
New +$199K ﹤0.01% 2406
2024
Q3 		– Sell
-10,552
Closed -$19K – 2938
2024
Q2 		$19K Sell
10,552
-207,087
-95% -$597K ﹤0.01% 2472
2024
Q1 		$1.04M Buy
217,639
+74,311
+52% +$261K ﹤0.01% 1638
2023
Q4 		$416K Buy
+143,328
New +$226K ﹤0.01% 1784
2023
Q2 		– Sell
-50,772
Closed -$148K – 2946
2023
Q1 		$148K Buy
50,772
+29,735
+141% +$150K ﹤0.01% 2449
2022
Q4 		$145K Buy
+21,037
New +$99.3K ﹤0.01% 2743
2021
Q2 		– Sell
-90,912
Closed -$1.13M – 3067
2021
Q1 		$1.13M Buy
+90,912
New +$1.39M 0.01% 1596
2018
Q4 		– Sell
-17,342
Closed -$556K – 1794
2018
Q3 		$556K Buy
+17,342
New +$527K ﹤0.01% 907

Other funds holding STIM

MAM
Madryn Asset Management New York $36.9M AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $782M AUM 62.56% 1-Year Est. Return
FCM
FourWorld Capital Management New York $110M AUM 44.07% 1-Year Est. Return
LG
Lane Generational Dover, Massachusetts $114M AUM 43.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
MCM
Masters Capital Management Atlanta, Georgia $3.9B AUM 50.88% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $928M AUM 596.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Marshall Wace's STIM Position: Q2 2026 in Review

Marshall Wace opened a new position in Neuronetics (STIM) in Q2 2026: 485,692 shares worth $631K. The stake represents ﹤0.01% of the portfolio and ranks #2412 among its holdings. This is a return to the name: Marshall Wace previously reported a position in STIM as recently as Q4 2025.

Marshall Wace first reported a position in STIM in Q3 2018 and has held it in 12 quarters since. The position peaked at $2.53M in Q3 2025. 87 funds tracked by Wall St. Rank hold STIM as of Q2 2026.

  • Marshall Wace held 485,692 shares of Neuronetics worth $631K as of Q2 2026.
  • Neuronetics was a new Marshall Wace position in Q2 2026.
  • Neuronetics made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2412 holding.
  • Marshall Wace first reported a position in Neuronetics in Q3 2018 and has held it in 12 quarters since.
  • Marshall Wace's Neuronetics position peaked at $2.53M in Q3 2025.
  • 87 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.